1. Porphyrias: An overview;Anderson,2020
2. The acute porphyrias;Wang,2020
3. Clinical guide and update on porphyrias;Stölzel;Gastroenterology [Internet],2019
4. Committe for Medicinal Products for Human Use (CHMP). EPAR. Givlaari® (givosiran). EMEA/H/C/004775/0000: European Medicines Agency (EMA); 2020.
5. Acute hepatic porphyrias: Recommendations for evaluation and long-term management;Balwani;Hepatology [Internet],2017